PHC Holdings Corporation (PHCCF)
| Market Cap | 896.07M +0.8% |
| Revenue (ttm) | 2.32B -0.1% |
| Net Income | 22.58M -40.0% |
| EPS | 0.18 -40.4% |
| Shares Out | n/a |
| PE Ratio | 39.68 |
| Forward PE | n/a |
| Dividend | 0.27 (4.25%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | n/a |
| Average Volume | 4,320 |
| Open | 6.42 |
| Previous Close | 6.42 |
| Day's Range | 6.42 - 6.42 |
| 52-Week Range | 5.98 - 7.09 |
| Beta | 0.78 |
| RSI | 30.74 |
| Earnings Date | May 11, 2026 |
About PHC Holdings
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer an... [Read more]
News
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
RUNCORN, United Kingdom--(BUSINESS WIRE)-- #AI--Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation (TSE: 6523), and Mindpeak, a leading provider of a...